Hai Long Zhu

GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ.

Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China.

Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China.

WatchTower Robotics Co. has developed a soft body, tether-less robot called Lighthouse that can find leaks early and accurately in water distribution pipes. The company is based in Cambridge, MA. The company's cloud-based analytics platform creates a "Google Maps of pipes" that highlights the leaks and informs the pipe operator of their location, size, and likelihood of catastrophic failure. The robot can be inserted into a pipe through an existing T-junction or hydrant, and each robot is optimized for one size pipe with the ability to adapt to 20% pipe diameter changes.

APT Electronics Co., Ltd. engages in the research, development, production and sales of light emitting diode (LED) packaging devices and application products. Its products include automotive, horticulture, mini LED, backlight, general lighting, and special lighting series. The company was founded by Ching Ho Chan and Guo Wei Xiao on August 30, 2006 and is headquartered in Guangzhou, China.

Xi'an Tianli Clad Metal Materials Co., Ltd. engages in the manufacture, research and development of clad metal plates and titanium alloy materials. The company's products include titanium-steel, stainless steel, zirconium-steel, tantalum-steel and silver-steel. The company was founded on December 25, 2003 and is headquartered in Xi'an, China.

WinnTi Medical Technology (Shanghai) Co., Ltd. engages in the manufacture and sale of orthopedic device. It specializes in spine and trauma. Its products include anterior cervical plate system, cervical reconstruction system, spine system, break off crosslink, regular plate system, locking plate system, pelvic plate system, variable angle locking plate system, locking plate system, rib stabilization system, cannulated screw system, and pin system. The company was founded by Junwen Wang on September 23, 2013 and is headquartered in Shanghai, China.

Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China.

Ningbo Taikang Pharmaceutical Technology Co. Ltd. is a private company that develops pharmaceutical technology. The company is based in Ningbo, China.

Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017.

Shanghai Ennovabio Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China.